January 7, 2020 / 9:21 AM / 11 days ago

BRIEF-GenOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance

Jan 7 (Reuters) - GENOWAY:

* GENOWAY EXTENDS ITS STRATEGIC ALLIANCE WITH MERCK

* GENOWAY ACQUIRES ADDITIONAL RIGHTS TO DEVELOP ALL ANIMAL CELL MODELS USING THE CRISPR/CAS9 SYSTEM

* LICENSE PROVIDES GENOWAY WITH NON-EXCLUSIVE RIGHTS TO COMMERCIALIZE DEVELOPMENT AND USE OF ALL OTHER ANIMAL CELL MODELS FOR ITS CUSTOMERS’ INTERNAL RESEARCH USES AS WELL AS COMMERCIAL EXPLOITATION

Source text for Eikon:

Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below